CCS Research Fellowships & Awards
CCS-BMS Hypertrophic Cardiomyopathy (HCM) Research Award
The Canadian Cardiovascular Society and Bristol Myers Squibb (BMS) are proud to support the CCS-BMS Hypertrophic Cardiomyopathy (HCM) Research Award. The purpose of this award is to foster growth of peer-reviewed Canadian research in the area of HCM, with a focus on HCM diagnosis, progression monitoring, epidemiology and/or prevalence.
Two (2) awards of up to $75,000 each will be awarded based on an independent peer review process. A total of $150,000 in funding is available across the two awards. Award funds will be administered by the Institution of the awardee’s affiliated university or equivalent.
Deadline Extended to MAY 29, 2026
CCS/Pfizer ATTR-CM Research Trainee Award
The Canadian Cardiovascular Society (CCS) and Pfizer have collaboratively created a research trainee award entitled “CCS-Pfizer ATTR-CM Research Trainee Award.” The purpose of this award is to foster the growth of peer-reviewed Canadian research in the area of Transthyretin Amyloid Cardiomyopathy (ATTR-CM). This award aims to foster excellence in cardiovascular research and help trainees advance toward independent research careers in the field of ATTR-CM.
One award of up to $60,000 will be awarded based on an independent peer review process. The funds may be used towards salary support/benefits, travel for attending a related conference/meeting, or operating expenses for research. Award funds will be administered by the Institution of the awardee’s affiliated university or equivalent.
Application Period: Closed
CCS-Novo Nordisk Cardiometabolic Research Award
The Canadian Cardiovascular Society (CCS) and Novo Nordisk are proud to support the 2025 CCS-Novo Nordisk Cardiometabolic Research Award. This award is intended for early career members for a research project on any topic related to cardiometabolic disease.
One award of $35,000 will be awarded based on an independent peer review process. Award funds will be administered by the Institution of the awardee’s affiliated university or equivalent.
Application Period: Closed
The Canadian Cardiovascular Society, Pfizer, and the Canadian Heart Function Alliance (CHF
Alliance) are proud to support the CCS/Pfizer/CHF Alliance Research Fellowship Award in First Nations, Inuit and Métis (FNIM) Communities Experiencing Heart Function (HF) Inequities. The purpose of this
award is to support growth and excellence in research focused on better understanding and
addressing the heart function inequities experienced by First Nations, Inuit and Métis, in both
health generally and HF care more specifically.
Application Period: Closed
For more information on developing a customized research fellowship or award with the CCS, please reach out to researchawards@ccs.ca.